Clinical Trials Directory

Trials / Completed

CompletedNCT01220661

Safety and Efficacy of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery

Phase 2 Study of One Dose Prophylactic Antibiotic in Laparoscopic Colorectal Surgery

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
312 (actual)
Sponsor
National Cancer Center, Korea · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In colorectal surgery, the use of prophylactic antibiotics is recommended. The standard use of antibiotics for colorectal surgery is three doses. It has been reported that the surgical site infection rates of laparoscopic colorectal surgery are lower than open colorectal surgery. However, the evidence of proper application of antibiotic for laparoscopic colorectal surgery is still not enough. The investigators are researching the efficacy and safety of one dose prophylactic antibiotic in laparoscopic colorectal surgery.

Detailed description

In colorectal surgery, the use of prophylactic antibiotics is recommended. The standard use of antibiotics for colorectal surgery is three doses. One randomized controlled study reported that surgical site infection rates of three doses prophylactic antibiotics are lower than those of one dose in colorectal surgery (4.3 versus 14.2%). But, surgical site infection rates between one dose and three doses were not different in laparoscopic subgroup of this study (11 versus 11%) It has been reported that the surgical site infection rates of laparoscopic colorectal surgery are lower than open colorectal surgery. However, the evidence of proper application of antibiotic for laparoscopic colorectal surgery is still not enough. The investigators are researching the efficacy and safety of one dose prophylactic antibiotic in laparoscopic colorectal surgery.

Conditions

Interventions

TypeNameDescription
DRUGCefotetanpreoperative one dose prophylactic antibiotic (2g iv, within 1 hour before skin incision)

Timeline

Start date
2010-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2010-10-14
Last updated
2011-12-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01220661. Inclusion in this directory is not an endorsement.